Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

Delayed Quote. Delayed  - 09/23 04:25:18 pm
41.6 NOK   +0.73%
09/13 PHOTOCURE ASA : Share capital increase registered
09/12 PHOTOCURE : Data published in World Journal of Urology show that Blu..
09/06 PHOTOCURE ASA : Update on management shareholdings and exercise of e..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Oslo Bors
09/19/2016 09/20/2016 09/21/2016 09/22/2016 09/23/2016 Date
41.2(c) 40.8(c) 40(c) 41.3(c) 41.6(c) Last
19 782 9 643 20 946 7 274 40 951 Volume
+0.98% -0.97% -1.96% +3.25% +0.73% Change
More quotes
Financials ( NOK)
Sales 2016 135 M
EBIT 2016 -22,5 M
Net income 2016 -3,47 M
Debt 2016 103 M
Yield 2016 -
Sales 2017 159 M
EBIT 2017 6,05 M
Net income 2017 5,63 M
Debt 2017 89,6 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 7,39x
EV / Sales2017 6,18x
Capitalization 896 M
More Financials
Company
Photocure ASA engages as a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment.It operates through Commercial Franchise and Development Portfolio segments.The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and... 
Sector
Pharmaceuticals
Calendar
11/15Earnings Release
More about the company
Surperformance© ratings of Photocure ASA
Trading Rating : Investor Rating :
More Ratings
Latest news on PHOTOCURE ASA
09/13 PHOTOCURE ASA : Share capital increase registered
09/12 PHOTOCURE : Data published in World Journal of Urology show that Blue Light Cyst..
09/06 PHOTOCURE ASA : Update on management shareholdings and exercise of employee shar..
08/29 PHOTOCURE : Hosts Bladder Cancer Key Opinion Leader Breakfast in New York City
08/24 PHOTOCURE : Hexvix® marketing authorization approval in Australia
08/23 PHOTOCURE : Presentation of the second quarter 2016 results and Hexvix/Cysview u..
08/23 PHOTOCURE : Results for second quarter and first half year 2016
08/23 PHOTOCURE ASA : Results for second quarter and first half year 2016
08/18PHOTOCURE ASA : half-yearly earnings release
08/17 PHOTOCURE ASA : Presentation of the second quarter 2016 results and Hexvix/Cysvi..
More news
Sector news : Pharmaceuticals - NEC
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/23 Endo International CEO steps down, Campanelli named successor
09/23DJSHIRE : Files 8K - Direct Or Off-Balance Sheet Financial Obligation
More sector news : Pharmaceuticals - NEC
Advertisement
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Full-screen chart
Technical analysis trends PHOTOCURE ASA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 50,0  NOK
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kjetil Hestdal President, Chief Executive Officer & Media Contact
Bente-Lill Bjerkelund Romøren Chairman
Erik Dahl Chief Financial Officer & IR Contact
Inger Ferner Heglund Vice President-Research & Development
Xavier Denis Yon Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHOTOCURE ASA-1.43%110
JOHNSON & JOHNSON15.66%325 050
ROCHE HOLDING LTD.-11.18%218 395
NOVARTIS AG-8.70%214 744
PFIZER INC.6.13%207 809
MERCK & CO., INC.19.20%174 098
More Results